Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
95,963,102
-
Total 13F shares
-
32,519,914
-
Share change
-
+871,305
-
Total reported value
-
$3,330,261,876
-
Put/Call ratio
-
177%
-
Price per share
-
$102.39
-
Number of holders
-
150
-
Value change
-
+$95,161,030
-
Number of buys
-
93
-
Number of sells
-
53
Institutional Holders of Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) as of Q2 2015
As of 30 Jun 2015,
Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) was held by
150 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,519,914 shares.
The largest 10 holders included
FMR LLC, Capital Research Global Investors, COLUMBIA WANGER ASSET MANAGEMENT LLC, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Fund Advisors, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, WELLS FARGO & COMPANY/MN, and JENNISON ASSOCIATES LLC.
This page lists
150
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.